Ji Yao Holding Group Co., Ltd. (300108.SZ)
CNY 1.11
(6.73%)
CNY 1.11
(6.73%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -225.02 Million CNY | -173.26% |
| 2022 | 7.52 Million CNY | 667.85% |
| 2021 | -210.72 Million CNY | -7.64% |
| 2020 | -176.38 Million CNY | -148.66% |
| 2019 | -1.48 Billion CNY | -89.71% |
| 2018 | 414.85 Million CNY | 20.36% |
| 2017 | 351.56 Million CNY | 13.12% |
| 2016 | 245.38 Million CNY | 37.96% |
| 2015 | 229.1 Million CNY | 103.76% |
| 2014 | 102.96 Million CNY | 87.61% |
| 2013 | 58.16 Million CNY | 9.29% |
| 2012 | 53.51 Million CNY | 39.35% |
| 2011 | 38.76 Million CNY | 15.96% |
| 2010 | 33.62 Million CNY | 27.7% |
| 2009 | 26.57 Million CNY | 39.07% |
| 2008 | 19.02 Million CNY | -6.66% |
| 2007 | 19.69 Million CNY | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q2 | -51.33 Million CNY | -150.53% |
| 2024 Q1 | -23.71 Million CNY | 88.4% |
| 2024 Q3 | -68.76 Million CNY | -18.69% |
| 2023 Q3 | -21.43 Million CNY | 36.89% |
| 2023 Q1 | 7.68 Million CNY | -93.27% |
| 2023 Q2 | -33.97 Million CNY | -542.0% |
| 2023 Q4 | -107.1 Million CNY | -399.57% |
| 2023 FY | - CNY | -173.26% |
| 2022 FY | - CNY | 667.85% |
| 2022 Q1 | -12.5 Million CNY | 78.52% |
| 2022 Q2 | -120.37 Million CNY | -862.89% |
| 2022 Q3 | -14.06 Million CNY | 88.31% |
| 2022 Q4 | 114.21 Million CNY | 911.82% |
| 2021 Q3 | -38.63 Million CNY | -493.98% |
| 2021 Q2 | -6.5 Million CNY | -51.08% |
| 2021 Q1 | -4.3 Million CNY | 94.59% |
| 2021 FY | - CNY | -7.64% |
| 2021 Q4 | -58.21 Million CNY | -50.67% |
| 2020 Q2 | -6.49 Million CNY | 70.58% |
| 2020 Q4 | -79.51 Million CNY | -2391.36% |
| 2020 FY | - CNY | -148.66% |
| 2020 Q3 | -3.19 Million CNY | 50.83% |
| 2020 Q1 | -22.06 Million CNY | 84.49% |
| 2019 Q1 | 49.8 Million CNY | -73.46% |
| 2019 FY | - CNY | -89.71% |
| 2019 Q4 | -142.25 Million CNY | -854.67% |
| 2019 Q3 | 18.84 Million CNY | -5.74% |
| 2019 Q2 | 19.99 Million CNY | -59.85% |
| 2018 Q1 | 54.74 Million CNY | -68.98% |
| 2018 FY | - CNY | 20.36% |
| 2018 Q4 | 187.64 Million CNY | 294.46% |
| 2018 Q3 | 47.57 Million CNY | -29.59% |
| 2018 Q2 | 67.55 Million CNY | 23.4% |
| 2017 FY | - CNY | 13.12% |
| 2017 Q1 | 21.85 Million CNY | -80.08% |
| 2017 Q3 | -54.36 Million CNY | -160.94% |
| 2017 Q4 | 176.51 Million CNY | 424.71% |
| 2017 Q2 | 89.2 Million CNY | 308.15% |
| 2016 FY | - CNY | 37.96% |
| 2016 Q3 | 61.55 Million CNY | 46.06% |
| 2016 Q2 | 42.14 Million CNY | -1.92% |
| 2016 Q1 | 42.97 Million CNY | 36.46% |
| 2016 Q4 | 109.74 Million CNY | 78.29% |
| 2015 Q1 | 48.46 Million CNY | 32.38% |
| 2015 Q2 | 63.91 Million CNY | 31.89% |
| 2015 Q3 | 51.65 Million CNY | -19.18% |
| 2015 FY | - CNY | 103.76% |
| 2015 Q4 | 31.48 Million CNY | -39.04% |
| 2014 Q4 | 36.6 Million CNY | 64.13% |
| 2014 FY | - CNY | 87.61% |
| 2014 Q3 | 22.3 Million CNY | 38.52% |
| 2014 Q2 | 16.1 Million CNY | 89.57% |
| 2014 Q1 | 8.49 Million CNY | -29.62% |
| 2013 Q1 | 5 Million CNY | 8.65% |
| 2013 FY | - CNY | 9.29% |
| 2013 Q2 | 16.45 Million CNY | 228.74% |
| 2013 Q3 | 5.04 Million CNY | -69.35% |
| 2013 Q4 | 12.06 Million CNY | 139.32% |
| 2012 Q4 | 4.6 Million CNY | -5.8% |
| 2012 Q1 | 9.26 Million CNY | 1.41% |
| 2012 FY | - CNY | 39.35% |
| 2012 Q3 | 4.89 Million CNY | -71.6% |
| 2012 Q2 | 17.22 Million CNY | 85.91% |
| 2011 Q1 | 8.37 Million CNY | 52.57% |
| 2011 Q2 | 9.52 Million CNY | 13.75% |
| 2011 Q3 | 6.57 Million CNY | -30.98% |
| 2011 Q4 | 9.13 Million CNY | 38.88% |
| 2011 FY | - CNY | 15.96% |
| 2010 Q4 | 5.49 Million CNY | -23.42% |
| 2010 Q2 | 8.73 Million CNY | 16.19% |
| 2010 Q3 | 7.17 Million CNY | -17.88% |
| 2010 FY | - CNY | 27.7% |
| 2010 Q1 | 7.51 Million CNY | 7.28% |
| 2009 Q4 | 7 Million CNY | 30.94% |
| 2009 Q3 | 5.34 Million CNY | 0.0% |
| 2009 FY | - CNY | 39.07% |
| 2008 FY | - CNY | -6.66% |
| 2007 FY | - CNY | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Cachet Pharmaceutical Co., Ltd. | 912.84 Million CNY | 124.651% |
| Yixintang Pharmaceutical Group Co., Ltd. | 2.18 Billion CNY | 110.312% |
| ZJAMP Group Co., Ltd. | 1.51 Billion CNY | 114.853% |
| Luyan Pharma Co.,Ltd. | 819.73 Million CNY | 127.451% |